Aline Bözec
Impact in
- Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Immunology top 2%
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
Papers in
- Immunology 35
- T-cell and B-cell Immunology 10
- Rheumatology 23
- Rheumatoid Arthritis Research and Therapies 12
- Co-authors
- Georg SchettZhu ChenAndreas RammingErwin F. WagnerMario M. ZaissYubin LuoDarja AndreevXiaoxiang Chen
In The Last Decade
Aline Bözec
103 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Rheumatology 1.2k
- Immunology 1.4k
- Cancer Research 539
- Orthopedics and Sports Medicine 306
- Oncology 886
Countries citing papers authored by Aline Bözec
This map shows the geographic impact of Aline Bözec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aline Bözec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aline Bözec more than expected).
Fields of papers citing papers by Aline Bözec
This network shows the impact of papers produced by Aline Bözec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aline Bözec. The network helps show where Aline Bözec may publish in the future.
Co-authors
The 25 scholars most cited alongside Aline Bözec, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 16 | |
| 6 | Bispecific T cell engager therapy for refractory rheumatoid arthritis Hit paper breakdown → | 2024 | 67 |
| 7 | 2023 | 2 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 14 | |
| 11 | 2021 | 19 | |
| 12 | 2020 | 62 | |
| 13 | 2020 | 127 | |
| 14 | 2020 | 25 | |
| 15 | 2019 | 17 | |
| 16 | 2019 | 26 | |
| 17 | 2017 | 29 | |
| 18 | 2011 | 24 | |
| 19 | 2008 | 17 | |
| 20 | 2007 | 25 |
About Aline Bözec
Aline Bözec is a scholar working on Immunology, Rheumatology, Cancer Research, Oncology and Orthopedics and Sports Medicine, having authored 111 papers that have together received 4.7k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (25 papers), Bone health and treatments (13 papers), Rheumatoid Arthritis Research and Therapies (12 papers), T-cell and B-cell Immunology (10 papers), Cytokine Signaling Pathways and Interactions (9 papers), CAR-T cell therapy research (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Cancer, Hypoxia, and Metabolism (8 papers). The work is most often cited by research in Rheumatology (1.2k citations), Immunology (1.4k citations), Cancer Research (539 citations), Orthopedics and Sports Medicine (306 citations) and Oncology (886 citations). Aline Bözec has collaborated with scholars based in Germany, China and France. Frequent co-authors include Georg Schett, Zhu Chen, Andreas Ramming, Erwin F. Wagner, Mario M. Zaiss, Yubin Luo, Darja Andreev, Xiaoxiang Chen, Xianyi Meng and Bettina Grötsch. Their work appears in journals such as Annals of the Rheumatic Diseases, Frontiers in Immunology, Bone, Journal of Clinical Investigation and Journal of Bone and Mineral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.